Studies have shown that circulating tumors (CTCs) activate platelet secretion of TGF-β, which induces platelets to accelerate or maintain CTC epithelial-mesenchymal transition (EMT) to promote abscission, migration, and invasion of tumor cells from the primary site (42). Here, TGFB1 is linked to neoplasm.